Tenet Healthcare (THC) Misses Q2 EPS by 14c, Offers FY16 & Q3 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Mizuho Securities Cuts Price Target on Tenet Healthcare (THC) to $28; Reiterates Neutral
August 2, 2016 8:11 AM EDTMizuho Securities maintained a Neutral rating on Tenet Healthcare (NYSE: THC), and cut the price target to $28.00 (from $33.00), following the company's 2Q earnings report.
Analyst Sheryl Skolnick commented, "The Mama issue is not a 'once and done, now it's behind them' thing. It's... More
